These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35311115)

  • 1. Targeting the lncRNA DUXAP8/miR-29a/
    Zhang L; Zhou S; Zhou T; Li X; Tang J
    Front Oncol; 2022; 12():773601. PubMed ID: 35311115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells.
    Shi X; Valizadeh A; Mir SM; Asemi Z; Karimian A; Majidina M; Safa A; Yosefi B
    Eur J Pharmacol; 2020 Aug; 880():173138. PubMed ID: 32416187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
    Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
    Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer.
    Ji X; Tao R; Sun LY; Xu XL; Ling W
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3152-3165. PubMed ID: 32271433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2.
    Yang Z; Ding H; Pan Z; Li H; Ding J; Chen Q
    Cancer Biol Ther; 2021 Mar; 22(3):216-224. PubMed ID: 33683171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DUXAP8 promotes the proliferation and migration of ovarian cancer cells via down-regulating microRNA-29a-3p expression.
    Li LM; Hao SJ; Ni M; Jin S; Tian YQ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1837-1844. PubMed ID: 33660793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
    Zhong S; Li W; Chen Z; Xu J; Zhao J
    Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of lncRNA-HOTAIR downregulates the drug-resistance of breast cancer cells to doxorubicin via the PI3K/AKT/mTOR signaling pathway.
    Li Z; Qian J; Li J; Zhu C
    Exp Ther Med; 2019 Jul; 18(1):435-442. PubMed ID: 31281438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
    Pang R; Yang S
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in clear cell renal cell carcinoma.
    He H; Wang N; Yi X; Tang C; Wang D
    Cell Biosci; 2017; 7():65. PubMed ID: 29214011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA (lncRNA) CTTN-IT1 Elevates Skeletal Muscle Satellite Cell Proliferation and Differentiation by Acting as ceRNA for
    Wu T; Wang S; Wang L; Zhang W; Chen W; Lv X; Li Y; Hussain Z; Sun W
    Front Genet; 2020; 11():843. PubMed ID: 32849826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-DUXAP8 Regulation of the Wnt/β-Catenin Signaling Pathway to Inhibit Glycolysis and Induced Apoptosis in Acute Myeloid Leukemia.
    Zhai H; Zhao J; Pu J; Zhao P; Wei J
    Turk J Haematol; 2021 Dec; 38(4):264-272. PubMed ID: 34431643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway.
    Lei C; Li S; Fan Y; Hua L; Pan Q; Li Y; Long Z; Yang R
    Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 36329030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA-H19 inhibits apoptosis of acute myeloid leukemia cells via targeting miR-29a-3p.
    Zhao TT; Liu X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):224-231. PubMed ID: 31389605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.
    Zhou S; Li J; Xu H; Zhang S; Chen X; Chen W; Yang S; Zhong S; Zhao J; Tang J
    Gene; 2017 Jul; 622():1-12. PubMed ID: 28431975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy.
    Liu K; Yao H; Wen Y; Zhao H; Zhou N; Lei S; Xiong L
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2871-2880. PubMed ID: 29807108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DUXAP8 knockdown inhibits the development of melanoma by regulating the miR-3182/NUPR1 pathway.
    Chen X; Gao J; Liang N
    Oncol Lett; 2021 Jul; 22(1):495. PubMed ID: 33981357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR-422a/PDK2 axis.
    Wei F; Yang L; Jiang D; Pan M; Tang G; Huang M; Zhang J
    Cancer Med; 2020 Apr; 9(7):2480-2490. PubMed ID: 32022476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA DUXAP8 regulates proliferation and apoptosis of ovarian cancer cells via targeting miR-590-5p.
    Meng Q; Li Z; Pan J; Sun X
    Hum Cell; 2020 Oct; 33(4):1240-1251. PubMed ID: 32749665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.